Skip to main content
ABVC BIOPHARMA, INC. logo

ABVC BIOPHARMA, INC. — Investor Relations & Filings

Ticker · ABVC ISIN · US00091F1066 US Manufacturing
Open in API
Filings indexed 780 across all filing types
Latest filing 2009-03-27 Director's Dealing
Country US United States of America
Listing US ABVC

About ABVC BIOPHARMA, INC.

https://abvcpharma.com/

ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company that develops and commercializes drugs and medical devices to address unmet medical needs. The company focuses on advancing a pipeline of botanical, plant-based pharmaceuticals and medical technologies sourced from research institutions. Its therapeutic areas of focus include oncology, ophthalmology, and central nervous system disorders such as major depressive disorder (MDD) and adult attention-deficit/hyperactivity disorder (ADHD). Key products in development include Vitargus®, a biodegradable vitreous substitute for eye surgery, and botanical drug candidates for MDD and ADHD. Additionally, its subsidiary, BioKey, Inc., offers contract development and manufacturing services for nutritional and pharmaceutical products.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2009-03-27 English
EQUITY 11 8TH TRANCHE
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, which is used for reporting unscheduled material events or corporate changes. The content describes an unregistered sale of equity securities (Convertible Preferred Shares and warrants) and references prior filings. It does not contain financial statements or detailed financial analysis but rather reports a specific capital transaction event. The document length is 4029 characters, which is relatively short and focused on a financing event. Therefore, this filing is best classified as a Capital/Financing Update (CAP).
2009-03-27 English
AMENDED 8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filing with the SEC, dated March 26, 2009, reporting the resignation of the Chief Financial Officer and appointment of a new CFO who retains other roles. The key section is Item 5.02, which relates to departure and appointment of officers. This clearly indicates a change in senior management. The document is not a full report but a current report on a material event, specifically management changes. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused solely on management changes, with no financial data or other report content.
2009-03-26 English
AMENDED 8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filing with the SEC, specifically reporting the resignation of the Chief Financial Officer and the appointment of a new CFO who retains other roles. The key section is ITEM 5.02, which relates to changes in officers and directors. There is no financial data or report content, only an announcement of management changes. Therefore, this fits the category of Board/Management Information (MANG). The document length is short and focused solely on management changes, confirming this classification.
2009-03-26 English
AMENDED 8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filing with the SEC, specifically reporting the resignation of the Chief Financial Officer and the appointment of a new CFO who retains other roles. The key section is ITEM 5.02, which relates to changes in officers and directors. There is no financial data or report content, only an announcement of management changes. Therefore, this fits the category of Board/Management Information (MANG). The document length is short and focused solely on management changes, confirming this classification.
2009-03-26 English
MORGAN RESIGNATION; STOLZ ELECTION
Board/Management Information Classification · 100% confidence The document is a Form 8-K current report filed with the SEC, dated March 26, 2009. The content specifically reports the resignation of the Chief Financial Officer and the appointment of a new CFO who retains other roles. This type of filing is related to changes in senior management or board members. The key section is ITEM 5.02, which deals with departure and election of officers. The document is short (2849 characters) and focuses solely on management changes without financial data or other report content. Therefore, it fits the category of Board/Management Information (MANG).
2009-03-26 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.